CUL4A and metabolic dysfunction-associated steatotic liver disease: The present study investigated the role of LINC01468 in the progression of NAFLD-HCC and showed that LINC01468 mediates lipogenesis, thereby promoting HCC progression through CUL4A-linked degradation of SHIP2 (Fig. 8J).